-
1
-
-
78650827771
-
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
-
Perzborn E, Roehrig S, Straub A, Kubitza D, Misselwitz F. The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. Nat Rev Drug Discov 2011;10:61-75.
-
(2011)
Nat Rev Drug Discov
, vol.10
, pp. 61-75
-
-
Perzborn, E.1
Roehrig, S.2
Straub, A.3
Kubitza, D.4
Misselwitz, F.5
-
2
-
-
84882909945
-
Novel oral anticoagulants: Clinical pharmacology, indications and practical considerations
-
Harder S, Graff J. Novel oral anticoagulants: Clinical pharmacology, indications and practical considerations. Eur J Clin Pharmacol 2013;69:1617-33.
-
(2013)
Eur J Clin Pharmacol
, vol.69
, pp. 1617-1633
-
-
Harder, S.1
Graff, J.2
-
3
-
-
84879529997
-
Importance of pharmacokinetic profi le and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban
-
Gong IY, Kim RB. Importance of pharmacokinetic profi le and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban. Can J Cardiol 2013;29(Suppl):S24-33.
-
(2013)
Can J Cardiol
, vol.29
-
-
Gong, I.Y.1
Kim, R.B.2
-
4
-
-
84874393418
-
Effi cacy and toxicity of factor Xa inhibitors
-
Bondarenko M, Curti C, Montana M, Rathelot P, Vanelle P. Effi cacy and toxicity of factor Xa inhibitors. J Pharm Pharma Sci 2013;16:74-88.
-
(2013)
J Pharm Pharma Sci
, vol.16
, pp. 74-88
-
-
Bondarenko, M.1
Curti, C.2
Montana, M.3
Rathelot, P.4
Vanelle, P.5
-
5
-
-
79951784125
-
Evaluation of drug-induced serious hepatotoxicity (EDISH): Application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery
-
Watkins PB, Desai M, Berkowitz SD, Peters G, Horsmans Y, Larrey D, et al. Evaluation of drug-induced serious hepatotoxicity (eDISH): Application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery. Drug Saf 2011;34:243-52.
-
(2011)
Drug Saf
, vol.34
, pp. 243-252
-
-
Watkins, P.B.1
Desai, M.2
Berkowitz, S.D.3
Peters, G.4
Horsmans, Y.5
Larrey, D.6
-
6
-
-
84907964271
-
Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban
-
Liakoni E, Rätz Bravo A, Terracciano L, Heim M, Krähenbühl S. Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban. JAMA Intern Med 2014;174:1683-6.
-
(2014)
JAMA Intern Med
, vol.174
, pp. 1683-1686
-
-
Liakoni, E.1
Rätz Bravo, A.2
Terracciano, L.3
Heim, M.4
Krähenbühl, S.5
-
7
-
-
84904725750
-
Rivaroxaban postmarketing risk of liver injury
-
Russmann S, Niedrig D, Budmiger M, Schmidt C, Stieger B, Hürlimann S, et al. Rivaroxaban postmarketing risk of liver injury. J Hepatol 2014;61:293-300.
-
(2014)
J Hepatol
, vol.61
, pp. 293-300
-
-
Russmann, S.1
Niedrig, D.2
Budmiger, M.3
Schmidt, C.4
Stieger, B.5
Hürlimann, S.6
-
8
-
-
79956295350
-
Case definition and phenotype standardization in drug-induced liver injury
-
Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 2011;89:806-15.
-
(2011)
Clin Pharmacol Ther
, vol.89
, pp. 806-815
-
-
Aithal, G.P.1
Watkins, P.B.2
Rade, R.J.3
Larrey, D.4
Molokhia, M.5
Takikawa, H.6
-
9
-
-
0027362542
-
Causality assessment of adverse reactions to drugs — I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
-
Danan G, Benichou C. Causality assessment of adverse reactions to drugs — I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30.
-
(1993)
J Clin Epidemiol
, vol.46
, pp. 1323-1330
-
-
Danan, G.1
Benichou, C.2
-
10
-
-
84893649169
-
Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment
-
Teschke R, Wolff A, Frenzel C, Schwarzenboeck A, Schulze J, Eickhoff A. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment. World J Hepatol 2014;6:17-32.
-
(2014)
World J Hepatol
, vol.6
, pp. 17-32
-
-
Teschke, R.1
Wolff, A.2
Frenzel, C.3
Schwarzenboeck, A.4
Schulze, J.5
Eickhoff, A.6
-
11
-
-
0037126649
-
U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
-
Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, et al. U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
-
(2002)
Ann Intern Med
, vol.137
, pp. 947-954
-
-
Ostapowicz, G.1
Fontana, R.J.2
Schiødt, F.V.3
Larson, A.4
Davern, T.J.5
Han, S.H.6
-
12
-
-
77952847965
-
Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: Unifi ed list based on international collaborative work
-
Suzuki A, Andrade RJ, Bjornsson E, Lucena MI, Lee WM, Yuen NA, et al. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: Unifi ed list based on international collaborative work. Drug Saf 2010;33:503-22.
-
(2010)
Drug Saf
, vol.33
, pp. 503-522
-
-
Suzuki, A.1
Rade, R.J.2
Bjornsson, E.3
Lucena, M.I.4
Lee, W.M.5
Yuen, N.A.6
-
13
-
-
0027448634
-
Causality assessment of adverse reactions to drugs — II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge
-
Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs — II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. J Clin Epidemiol 1993;46:1331-6.
-
(1993)
J Clin Epidemiol
, vol.46
, pp. 1331-1336
-
-
Benichou, C.1
Danan, G.2
Flahault, A.3
-
15
-
-
40849111658
-
Assessment of drug-induced liver injury in clinical practice
-
Lucena MI, García-Cortés M, Cueto R, Lopez-Duran J, Andrade RJ. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol 2008;22:141-58.
-
(2008)
Fundam Clin Pharmacol
, vol.22
, pp. 141-158
-
-
Lucena, M.I.1
García-Cortés, M.2
Cueto, R.3
Lopez-Duran, J.4
Rade, R.J.5
-
16
-
-
84886852658
-
Hyperacute drug-induced hepatits with intravenous amiodarone: Case report and review of the literature
-
Nasser M, Larsen TR, Waanbah B, Sidiqi I, McCullough PA. Hyperacute drug-induced hepatits with intravenous amiodarone: Case report and review of the literature. Drug Healthc Patient Saf 2015;5:191-8.
-
(2015)
Drug Healthc Patient Saf
, vol.5
, pp. 191-198
-
-
Nasser, M.1
Larsen, T.R.2
Waanbah, B.3
Sidiqi, I.4
McCullough, P.A.5
|